← Back
Data updated: Mar 10, 2026
TAMARANG
Pharmaceuticals
TAMARANG is a generic drug manufacturer with 1 FDA-approved products.
2012
Since
1
Drugs
-
Trials
8
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ROCURONIUM BROMIDE 2026-01-06
ROCURONIUM BROMIDE 2025-10-24
ROCURONIUM BROMIDE 2025-06-24
Labeling
ROCURONIUM BROMIDE 2025-06-09
Type 5 - New Formulation or New Manufacturer
ROCURONIUM BROMIDE 2025-05-29
ROCURONIUM BROMIDE 2024-07-22
ROCURONIUM BROMIDE 2024-07-12
ROCURONIUM BROMIDE 2024-07-12
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Active (1)
Discontinued (0)
Company Info
- First Approval
- 2012-08-27
- Latest
- 2019-05-29
- Applications
- 1